Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis

Haploidentical stem cell transplantation (haploSCT) has greatly improved access to curative treatment for myeloid malignancies in patients without suitable matched sibling/unrelated donors. We investigated the safety and efficacy of haploSCT after reduced intensity conditioning (RIC) with anti-thymo...

Full description

Bibliographic Details
Main Authors: Maria Queralt Salas, Arjun Datt Law, Wilson Lam, Zeyad Al-Shaibani, David Loach, Dennis (Dong Hwan) Kim, Fotios V. Michelis, Santhosh Thyagu, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Auro Viswabandya
Format: Article
Language:English
Published: Atlantis Press 2019-06-01
Series:Clinical Hematology International
Subjects:
Haploidentical hematopoietic cell transplantation
T-cell replete grafts
Post-transplant cyclophosphamide
Anti-thymocyte globulin
Myeloid malignancies
Graft-versus-host disease
Online Access:https://www.atlantis-press.com/article/125908014/view

Internet

https://www.atlantis-press.com/article/125908014/view

Similar Items